Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L) Comparison with companies in other sectors?

Eckert & Ziegler Strahlen- und Medizintechnik AG has a share price of 5.06M. You can analyze Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L) competitors across different market sectors through stock heatmaps.

What are 0NZY.L's NET and operating margins?

Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L) operating margin is around 0.21, and net profit margin is approximately 0.12 as of the latest reports.

In what way does 0NZY.L's earnings per share (EPS) trend reflect its financial momentum?

Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L) EPS is 1.30 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Eckert & Ziegler Strahlen- und Medizintechnik AG is 30.50, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Eckert & Ziegler Strahlen- und Medizintechnik AG?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Eckert & Ziegler Strahlen- und Medizintechnik AG like P/E which is 59.69, P/B which is 9.74, and PEG which is -5.47. Compare them with sector averages to evaluate if the stock is priced fairly.

Eckert & Ziegler Strahlen- und Medizintechnik AG

0NZY.L•LSE

Healthcare

Medical - Pharmaceuticals

£39.74

£0.01(0.03%)

Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$1.30

P/E Ratio

30.50

ROE

0.16%

Net Margin

0.12%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$201.21M

Shares OutstandingTotal number of shares issued

$5.06M

Book Value/ShareNet worth per share

$1.81

Revenue/ShareAnnual revenue per share

$2.39

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$1.303

Net MarginNet income as percentage of revenue

12.24%

Operating MarginOperating income as percentage of revenue

21.41%

ROEReturn on shareholders' equity

15.81%

ROAReturn on total assets

8.35%

ROCEReturn on capital employed

17.70%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.45

Cash/ShareCash and equivalents per share

$0.90

FCF YieldFree cash flow as percentage of market cap

5.19%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.50

Dividend YieldAnnual dividend as percentage of stock price

2.86%

Financial Ratios Analysis data is not available for 0NZY.LFinancial Ratios Analysis details for 0NZY.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 0NZY.LSector Benchmarking details for 0NZY.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Eckert & Ziegler Strahlen- und Medizintechnik AG Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Eckert & Ziegler Strahlen- und Medizintechnik AG. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Eckert & Ziegler Strahlen- und Medizintechnik AG's unique business strengths and challenges.

Key Financial Metrics for Eckert & Ziegler Strahlen- und Medizintechnik AG

For Eckert & Ziegler Strahlen- und Medizintechnik AG, essential financial indicators include EPS 1.30, PE 30.50, and ROE 0.16. These key ratios reveal insights into Eckert & Ziegler Strahlen- und Medizintechnik AG's profitability, valuation, and operational health. Understanding these metrics enables you to compare Eckert & Ziegler Strahlen- und Medizintechnik AG with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Eckert & Ziegler Strahlen- und Medizintechnik AG

Metrics like Net Margin 12.24% and ROA 8.35% shed light on how well Eckert & Ziegler Strahlen- und Medizintechnik AG is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Eckert & Ziegler Strahlen- und Medizintechnik AG can sustain its operations and continue growing in the future.

Valuation and Market Position of Eckert & Ziegler Strahlen- und Medizintechnik AG

Using ratios such as P/B Ratio 9.74 and PEG Ratio -5.47, investors can assess whether Eckert & Ziegler Strahlen- und Medizintechnik AG is appropriately valued based on its financials and growth potential. These figures, combined with Eckert & Ziegler Strahlen- und Medizintechnik AG's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Eckert & Ziegler Strahlen- und Medizintechnik AG

Financial health indicators, such as Debt/Equity Ratio 0.22 and Cash Flow $0.45, provide a snapshot of Eckert & Ziegler Strahlen- und Medizintechnik AG's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Eckert & Ziegler Strahlen- und Medizintechnik AG, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Eckert & Ziegler Strahlen- und Medizintechnik AG

Investing in Eckert & Ziegler Strahlen- und Medizintechnik AG based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Eckert & Ziegler Strahlen- und Medizintechnik AG focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;